Pro-inflammatory cytokine network and anti-inflammatory mediators

The pro-inflammatory cytokine network and anti-inflammatory mediators represent a complex system of signaling proteins that regulate the intensity and duration of the immune response (Dinarello, 2000). Pro-inflammatory cytokines, such as TNF-alpha, IL-1, and IL-6, are primarily responsible for initiating the inflammatory cascade to combat pathogens and repair tissue (Opal & DePalo, 2000). In contrast, anti-inflammatory mediators like IL-10 and TGF-beta serve as essential feedback inhibitors that prevent excessive tissue damage and promote the resolution of inflammation (Nature Reviews Immunology, 2018). An imbalance in this network, often characterized by a 'cytokine storm' or chronic low-grade inflammation, is a central driver in diseases ranging from rheumatoid arthritis to sepsis (PubMed, 2021). Therapeutic intervention focuses on modulating specific components of this network to suppress overactive pathways or bolster regulatory mechanisms, thereby restoring physiological balance (StatPearls, 2023). Because this entry describes a broad biological system rather than a single discrete protein or receptor, it is classified as a network rather than a specific therapeutic target.

Other names

Cytokine networkInflammatory mediator systemCytokine balancePro-inflammatory and anti-inflammatory cytokine balance

Drugs targeting this network typically act by neutralizing specific pro-inflammatory cytokines (e.g., TNF-alpha, IL-6), blocking their cognate receptors to prevent signal transduction, or mimicking natural anti-inflammatory mediators to restore immunological homeostasis (StatPearls, 2023; Dinarello, 2000).